Canine Parvovirus and Its Non-Structural Gene 1 as Oncolytic Agents: Mechanism of Action and Induction of Anti-Tumor Immune Response
The exploration into the strategies for the prevention and treatment of cancer is far from complete. Apart from humans, cancer has gained considerable importance in animals because of increased awareness towards animal health and welfare. Current cancer treatment regimens are less specific towards t...
Main Authors: | Richa Arora, Waseem Akram Malla, Arpit Tyagi, Sonalika Mahajan, Basavaraj Sajjanar, Ashok Kumar Tiwari |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.648873/full |
Similar Items
-
Tumor selectivity of oncolytic parvoviruses: from in vitro and animal models to cancer patients
by: Assia L Angelova, et al.
Published: (2015-04-01) -
The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers
by: Assia L. Angelova, et al.
Published: (2017-05-01) -
Canine parvovirus induces G1/S cell cycle arrest that involves EGFR Tyr1086 phosphorylation
by: Xiaofeng Dai, et al.
Published: (2020-12-01) -
Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
by: Assia L. Angelova, et al.
Published: (2017-12-01) -
Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients
by: Clara Martín-Carrasco, et al.
Published: (2022-06-01)